Filing Analysis
Aeluma, Inc. filed a Form 8-K on May 19, 2026, to furnish an updated investor presentation under Item 7.01. The company intends to use this presentation in upcoming meetings with analysts, investors, and other parties.
📋 Key Facts
- Aeluma, Inc. updated its investor presentation on May 19, 2026.
- The presentation is furnished as Exhibit 99.1 and incorporated by reference into Item 7.01.
- The information in the report is furnished and not deemed 'filed' under Section 18 of the Exchange Act.
Aeluma, Inc. announced its financial results for the third fiscal quarter ended March 31, 2026, via a press release. The filing serves as a formal notification of the earnings release and coincides with the filing of their Form 10-Q.
📋 Key Facts
- Announced Q3 2026 financial results for the period ending March 31, 2026.
- Press release furnished as Exhibit 99.1.
- Company is classified as an emerging growth company.
- Filing date of May 13, 2026.
Aeluma, Inc. entered into a sales agreement with Roth Capital Partners and other agents to establish an at-the-market (ATM) equity offering program. The company may sell up to $50.0 million of its common stock from time to time at prevailing market prices.
🚩 Red Flags
- Potential for significant shareholder dilution given the $50.0 million offering cap relative to typical micro-cap valuations.
📋 Key Facts
- Agreement dated March 20, 2026, with Roth Capital Partners, Craig-Hallum, Northland Securities, and The Benchmark Company.
- The offering allows for the sale of common stock up to an aggregate price of $50.0 million.
- Sales will be conducted as 'at-the-market' offerings on the Nasdaq Capital Market.
- The shares are issued under an existing shelf registration statement on Form S-3 (No. 333-289135) effective since August 8, 2025.
- The company is not obligated to sell any shares and can terminate the agreement with 5 business days' notice.